APGE · CIK 0001974640 · operating
Apogee Therapeutics, Inc. (APGE) is a biological products, (no diagnostic substances) company, listed on the Nasdaq. With a market capitalization of $4.8 billion, Apogee Therapeutics, Inc. is a mid-cap company. The stock currently trades at $70.92, up 1.31% today, with a 52-week range of $26.20–$84.56.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2025 | $-4.22 | $-4.22 | -27.9% | |
| 2024 | $-3.30 | $-3.30 | +1.8% | |
| 2023 | $-3.36 | $-3.36 | — |